The Korean Journal of Medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Chronic Hepatitis B in Pregnancy

임신과 만성 B형 간염

  • Gwak, Geum-Youn (Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • 곽금연 (성균관대학교 의과대학 삼성서울병원 내과학교실)
  • Published : 2012.07.01
⟨ Previous Next ⟩

Abstract

Hepatitis B virus (HBV) infection during pregnancy brings up unique management challenges. Varying aspects of care must be considered, including the effects of pregnancy on the course of HBV infection, effects of HBV infection on maternal and fetal health, treatment of HBV during and after pregnancy, and prevention of perinatal infection. For those with chronic HBV infection, the course of disease is usually unchanged during pregnancy. However, flares have been reported shortly after delivery. Women with high HBV DNA titer have an increased likelihood of perinatal transmission and may contribute to the failure of current passive-active immunoprophylaxis at birth. The aim of the present review is to provide a tool that may help physicians to manage correctly HBV infection in pregnancy.

Keywords

References

  1. Jonas MM. Hepatitis B and pregnancy: an underestimated issue. Liver Int 2009;29(Suppl 1):S133-S139.
  2. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004;11:97-107. https://doi.org/10.1046/j.1365-2893.2003.00487.x
  3. McMahon BJ, Alward WL, Hall DB, et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 1985;151:599-603. https://doi.org/10.1093/infdis/151.4.599
  4. Nguyen G, Garcia RT, Nguyen N, Trinh H, Keeffe EB, Nguyen MH. Clinical course of hepatitis B virus infection during pregnancy. Aliment Pharmacol Ther 2009;29:755-764. https://doi.org/10.1111/j.1365-2036.2009.03932.x
  5. Hay JE. Liver disease in pregnancy. Hepatology 2008;47:1067-1076. https://doi.org/10.1002/hep.22130
  6. Ter Borg MJ, Leemans WF, de Man RA, Janssen HL. Exacerbation of chronic hepatitis B infection after delivery. J Viral Hepat 2008;15:37-41.
  7. Mahtab MA, Rahman S, Khan M, Mamun AA, Afroz S. Etiology of fulminant hepatic failure: experience from a tertiary hospital in Bangladesh. Hepatobiliary Pancreat Dis Int 2008;7:161-164.
  8. Yang YB, Li XM, Shi ZJ, Ma L. Pregnant woman with fulminant hepatic failure caused by hepatitis B virus infection: a case report. World J Gastroenterol 2004;10:2305-2306.
  9. Beasley RP, Trepo C, Stevens CE, Szmuness W. The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol 1977;105:94-98.
  10. Wong VC, Ip HM, Reesink HW, et al. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin: doubleblind randomised placebo-controlled study. Lancet 1984;1:921-926.
  11. Okada K, Kamiyama I, Inomata M, Imai M, Miyakawa Y. e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med 1976;294:746-749. https://doi.org/10.1056/NEJM197604012941402
  12. Bai H, Zhang L, Ma L, Dou XG, Feng GH, Zhao GZ. Relationship of hepatitis B virus infection of placental barrier and hepatitis B virus intra-uterine transmission mechanism. World J Gastroenterol 2007;13:3625-3630.
  13. Wang JS, Chen H, Zhu QR. Transformation of hepatitis B serologic markers in babies born to hepatitis B surface antigen positive mothers. World J Gastroenterol 2005;11:3582-3585.
  14. Xu DZ, Yan YP, Choi BC, et al. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a casecontrol study. J Med Virol 2002;67:20-26. https://doi.org/10.1002/jmv.2187
  15. Tran TT. Management of hepatitis B in pregnancy: weighing the options. Cleve Clin J Med 2009;76(Suppl 3):S25-S29.
  16. Wiseman E, Fraser MA, Holden S, et al. Perinatal transmission of hepatitis B virus: an Australian experience. Med J Aust 2009;190:489-492.
  17. Han GR, Cao MK, Zhao W, et al. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection. J Hepatol 2011;55:1215-1221. https://doi.org/10.1016/j.jhep.2011.02.032
  18. Bzowej NH. Hepatitis B therapy in pregnancy. Curr Hepat Rep 2010;9:197-204. https://doi.org/10.1007/s11901-010-0059-x
  19. Zhang SL, Yue YF, Bai GQ, Shi L, Jiang H. Mechanism of intrauterine infection of hepatitis B virus. World J Gastroenterol 2004;10:437-438.
  20. Tarantal AF, Castillo A, Ekert JE, Bischofberger N, Martin RB. Fetal and maternal outcome after administration of tenofovir to gravid rhesus monkeys (Macaca mulatta). J Acquir Immune Defic Syndr 2002;29:207-220.
  21. Van Rompay KK, Durand-Gasselin L, Brignolo LL, et al. Chronic administration of tenofovir to rhesus macaques from infancy through adulthood and pregnancy: summary of pharmacokinetics and biological and virological effects. Antimicrob Agents Chemother 2008;52:3144-3160. https://doi.org/10.1128/AAC.00350-08
  22. Foster C, Lyall H, Olmscheid B, Pearce G, Zhang S, Gibb DM. Tenofovir disoproxil fumarate in pregnancy and prevention of mother-to-child transmission of HIV-1: is it time to move on from zidovudine? HIV Med 2009;10:397-406. https://doi.org/10.1111/j.1468-1293.2009.00709.x
  23. Antiretroviral Pregnancy Registry. Available from: http://www.apregistry.com.
  24. Munderi P, Wilkes H, Tumukunde D, et al. Pregnancy and outcomes among women on triple-drug antiretroviral therapy (ART) in the DART trial [poster WEPEB261]. Poster presented at: 5th IAS Conference on HIV Pathogenesis, Treatment and Prevention. Cape town, South Africa: IAS, 2009.
  25. Del Canho R, Grosheide PM, Mazel JA, et al. Ten-year neonatal hepatitis B vaccination program, the Netherlands, 1982-1992: protective efficacy and long-term immunogenicity. Vaccine 1997;15:1624-1630. https://doi.org/10.1016/S0264-410X(97)00080-7
  26. Ngui SL, Andrews NJ, Underhill GS, Heptonstall J, Teo CG. Failed postnatal immunoprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors. Clin Infect Dis 1998;27:100-106. https://doi.org/10.1086/514610
  27. Xu WM, Cui YT, Wang L, et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat 2009;16:94-103 https://doi.org/10.1111/j.1365-2893.2008.01056.x
  28. Korean Association for the Study of the Liver. KASL Clinical Practice Guidelines: Management of chronic hepatitis B [Internet]. Seoul: Korean Association for the Study of the Liver, c2011 [cited 2011 Dec 8]. Available from: http://www. kasl.org/down_guide/2011_guideline_HBV.pdf.
  29. Yang J, Zeng XM, Men YL, Zhao LS. Elective caesarean section versus vaginal delivery for preventing mother to child transmission of hepatitis B virus: a systematic review. Virol J 2008;5:100. https://doi.org/10.1186/1743-422X-5-100
  30. Beasley RP, Stevens CE, Shiao IS, Meng HC. Evidence against breast-feeding as a mechanism for vertical transmission of hepatitis B. Lancet 1975;2:740-741.
  31. Hill JB, Sheffield JS, Kim MJ, Alexander JM, Sercely B, Wendel GD. Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriers. Obstet Gynecol 2002;99:1049-1052. https://doi.org/10.1016/S0029-7844(02)02000-8
  32. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009;50:661-662. https://doi.org/10.1002/hep.23190